TY  - BOOK
AU  - Norris,Sheena M.Posey
AU  - Strauss,Evelyn
AU  - De Feo,Christopher Joseph
AU  - Stroud,Clare
ED  - Financial Incentives to Encourage Development of Therapies That Address Unmet Medical Needs for Nervous System Disorders (Workshop)
ED  - Institute of Medicine (U.S.).
ED  - Institute of Medicine (U.S.).
TI  - Financial incentives to encourage development of therapies that address unmet medical needs for nervous system disorders: workshop summary 
SN  - 9780309373241
AV  - RM301.25 .N67 2015
U1  - 615.19 23
PY  - 2015///
CY  - Washington, D.C.
PB  - National Academies Press
KW  - Drug development
KW  - Economic aspects
KW  - Congresses
KW  - Central nervous system
KW  - Diseases
KW  - Effect of drugs on
KW  - Pharmaceutical industry
KW  - Public-private sector cooperation
KW  - Central Nervous System Agents
KW  - economics
KW  - Drug Discovery
KW  - Financial Support
KW  - Nervous System Diseases
KW  - drug therapy
KW  - Private Sector
KW  - MEDICAL
KW  - Pharmacology
KW  - bisacsh
KW  - fast
KW  - Congress
KW  - Electronic books
KW  - Conference papers and proceedings
N1  - Title from PDF title page; Includes bibliographical references; Introduction and overview -- Improving market protection -- Strengthening the regulatory pathway -- Patient benefit and engagement
N2  - The Institute of Medicine (IOM) Forum on Neuroscience and Nervous System Disorders, in collaboration with the IOM Forum on Drug Discovery, Development, and Translation, convened a workshop on January 20-21, 2015, to explore policy changes that might increase private sector investment in research and development innovation that fills unmet medical needs for central nervous system (CNS) disorders. Workshop participants strategized about how to incentivize companies to fortify their CNS drug development programs, shrinking obstacles that currently deter ventures. Representatives from academia, government agencies, patient groups, and industry gathered to share information and viewpoints, and to brainstorm about budget-neutral policy changes that could help widen the pipeline toward drugs that address unmet needs for CNS disorders. This report summarizes the presentations and discussion of the workshop
UR  - https://libproxy.firstcity.edu.my:8443/login?url=http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1029476
ER  -